CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Mar 22, 2023. (Total: 4244 publications since 2011)

All Cancer Diabetes Economic Environmental Equity FHH HLBS Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search CDC Author Year Journal

Records 1-15 (of 15 Records)

Query Trace: all>>Jeffrey A Johnson[CDC Author]
Transmitted Drug Resistance Among HIV-1 Diagnoses in the United States, 2014-2018. R Paul McClung, Alexandra M Oster, M Cheryl Bañez Ocfemia, Neeraja Saduvala, Walid Heneine, Jeffrey A Johnson, and Angela L Hernandez Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021 Similar articles in PubMed DOI:10.1093/cid/ciab583
Do I Have HIV or Not? Lack of RNA Detection and the Case for Sensitive DNA Testing. Sandra A Springer, Silvina Masciotra, Jeffrey A Johnson, and Sheldon Campbell Open forum infectious diseases 2020 Nov 7(11) ofaa478 Similar articles in PubMed DOI:10.1093/ofid/ofaa478
Phylodynamic Analysis Complements Partner Services by Identifying Acute and Unreported HIV Transmission. Ellsworth M Campbell, Anne Patala, Anupama Shankar, Jin-Fen Li, Jeffrey A Johnson, Emily Westheimer, Cynthia L Gay, Stephanie E Cohen, William M Switzer, and Philip J Peters Viruses 2020 Jan (2) Similar articles in PubMed DOI:10.3390/v12020145
Natural selection favoring more transmissible HIV detected in United States molecular transmission network. Joel O Wertheim, Alexandra M Oster, William M Switzer, Chenhua Zhang, Nivedha Panneer, Ellsworth Campbell, Neeraja Saduvala, Jeffrey A Johnson, and Walid Heneine Nature communications 2019 Dec (1) 5788 Similar articles in PubMed DOI:10.1038/s41467-019-13723-z
Maintenance and reappearance of extremely divergent intra-host HIV-1 variants. Joel O Wertheim, Alexandra M Oster, Ben Murrell, Neeraja Saduvala, Walid Heneine, William M Switzer, and Jeffrey A Johnson Virus evolution 2018 Jul (2) vey030 Similar articles in PubMed DOI:10.1093/ve/vey030
Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network. Joel O Wertheim, Alexandra M Oster, Jeffrey A Johnson, William M Switzer, Neeraja Saduvala, Angela L Hernandez, H Irene Hall, and Walid Heneine Virus evolution 2017 Jan 3(1) vex008 Similar articles in PubMed DOI:10.1093/ve/vex008
Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups. Jin-Fen Li, Laurie Linley, Richard Kline, Rebecca Ziebell, Walid Heneine, and Jeffrey A Johnson AIDS (London, England) 2016 Mar Similar articles in PubMed DOI:10.1097/QAD.0000000000001099
Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy. Masako Nishizawa, Masakazu Matsuda, Junko Hattori, Teiichiro Shiino, Tetsuro Matano, Walid Heneine, Jeffrey A Johnson, and Wataru Sugiura PLoS ONE 2015 (9) e0135941 Similar articles in PubMed DOI:10.1371/journal.pone.0135941
HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences. Jonathan T Lipscomb, William M Switzer, Jin-Fen Li, Silvina Masciotra, S Michele Owen, and Jeffrey A Johnson The Journal of infectious diseases 2014 Dec (11) 1827-37 Similar articles in PubMed DOI:10.1093/infdis/jiu333
Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan. Masako Nishizawa, Junko Hattori, Teiichiro Shiino, Tetsuro Matano, Walid Heneine, Jeffrey A Johnson, and Wataru Sugiura PloS one 2013 8(12) e83150 Similar articles in PubMed DOI:10.1371/journal.pone.0083150
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz. Anna Maria Geretti, Tim Conibear, Andrew Hill, Jeffrey A Johnson, Lotke Tambuyzer, Kim Thys, Johan Vingerhoets, Yvon van Delft, and J. Antimicrob. Chemother. 2014 Apr 69(4) 1090-7 Similar articles in PubMed DOI:10.1093/jac/dkt474
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure. Jonathan Z Li, Roger Paredes, Heather J Ribaudo, Michael J Kozal, Evguenia S Svarovskaia, Jeffrey A Johnson, Anna Maria Geretti, Karin J Metzner, Martin R Jakobsen, Katherine Huppler Hullsiek, Lars Ostergaard, Michael D Miller, and Daniel R Kuritzkes J. Infect. Dis. 2013 Mar 15. 207(6) 893-7 Similar articles in PubMed DOI:10.1093/infdis/jis925
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. Jonathan Z Li, Roger Paredes, Heather J Ribaudo, Evguenia S Svarovskaia, Karin J Metzner, Michael J Kozal, Kathy Huppler Hullsiek, Melanie Balduin, Martin R Jakobsen, Anna Maria Geretti, Rodolphe Thiebaut, Lars Ostergaard, Bernard Masquelier, Jeffrey A Johnson, Michael D Miller, and Daniel R Kuritzkes JAMA 2011 Apr 6. 305(13) 1327-35 Similar articles in PubMed DOI:10.1001/jama.2011.375
Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections. Jin-Fen Li, Jonathan T Lipscomb, Xierong Wei, Neil A Martinson, Lynn Morris, Walid Heneine, and Jeffrey A Johnson The Journal of infectious diseases 2011 Mar 203(6) 798-802 Similar articles in PubMed DOI:10.1093/infdis/jiq126
Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance. Xierong Wei, Ae S Youngpairoj, Carolina Garrido, Natalia Zahonero, Angelica Corral, Carmen de Mendoza, Walid Heneine, Jeffrey A Johnson, and J Gerardo Garcia-Lerma Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2011 Feb 50(2) 148-52 Similar articles in PubMed DOI:10.1016/j.jcv.2010.11.006